Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Ceribulin 0.88mg Injection
Manufacturer/Marketed By : CELON LABORATORIES LTD
$349.87 $125.95
Ceribulin 0.88mg Injection is a chemotherapy drug that contains the active substance eribulin, which belongs to the class of antineoplastic agents. Ceribulin 0.88mg Injection is used in adults for advanced...
ERIBULIN
Active Pharmaceutical Ingredient
Ceribulin 0.88mg Injection
$349.87
$125.95
Ceribulin 0.88mg Injection is a chemotherapy drug that contains the active substance eribulin, which belongs to the class of antineoplastic agents. Ceribulin 0.88mg Injection is used in adults for advanced breast cancer or liposarcoma (a type of cancer originating from fat tissue) when other treatments have stopped working. It is not recommended to take Ceribulin 0.88mg Injection if you are allergic to Eribulin or any of its other ingredients. Consult your doctor if you believe this applies to you. It is not recommended for children and adolescents younger than 18 years since the effects of Ceribulin 0.88mg Injection in this population are unknown. Before starting the treatment, you should inform your physician if you have fever, infections, liver, or heart problems. Before starting the treatment, give a detailed account of your medical history and medications.
Active Pharmaceutical Ingredient
Uses
• Advanced breast cancer
• Liposarcoma
Benefits
Ceribulin 0.88mg Injection stops the growth and spread of cancer cells, specifically targeting the growth phase of microtubules, which are structures that help cells divide. It prevents them from growing without interfering with their shrinking phase. Additionally, it causes tubulin, a protein essential for cell division, to clump together in a way that disrupts cell division. This ultimately leads to the blockage of the cell cycle (G2/M phase), disrupting the formation of structures necessary for cell division (mitotic spindles) and triggering cell death through apoptosis.
Side Effects
Side effects are unwanted symptoms that occur due to medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Decrease in the number of white blood cells or red blood cells
• Tiredness or weakness
• Nausea, vomiting, constipation, diarrhea
• Numbness, tingling or prickling sensations
• Fever
• Loss of appetite, weight loss
• Difficulty breathing, cough
• Pain in the joints, muscles, and back
• Headache
• Hair loss
Common Side Effects
• Sepsis (severe infection)
• Severe allergic reaction
• Serious skin conditions (Stevens-Johnson syndrome)
How To Use
Ceribulin 0.88mg Injection will be given to you by your healthcare provider. It is injected directly into a vein (intravenous infusion) in a cycle. Your healthcare provider determines the dose, duration, and frequency based on your age, body weight, and severity of your condition. If you forget or miss your Ceribulin 0.88mg Injection cycle dose, make another appointment as soon as possible. Do not wait until your next planned visit. Do not stop the treatment without physician advice.
Safety Advice
• Breast Feeding: Ceribulin 0.88mg Injection is not recommended while breastfeeding since it is unknown whether it passes through breast milk. Inform your doctor if you are breastfeeding or planning to breastfeed before starting the treatment with Ceribulin 0.88mg Injection.
• Alcohol: Ceribulin 0.88mg Injection contains small amounts of alcohol. Hence, it is generally recommended that patients taking Ceribulin 0.88mg Injection avoid or limit their alcohol intake, as alcohol can enhance the risk of liver damage and exacerbate any liver-related side effects of Ceribulin 0.88mg Injection.
• Liver: Ceribulin 0.88mg Injection can affect the liver's normal functioning, causing abnormalities in liver function tests. Hence, you should inform your healthcare provider if you have pre-existing liver problems before starting this treatment.
• Lungs: Ceribulin 0.88mg Injection can cause side effects like blood clots in the lungs and inflammation of the lungs. Inform your doctor if you have ever had lung disorders before starting the treatment, as its symptoms may worsen with Ceribulin 0.88mg Injection.
• Driving: Ceribulin 0.88mg Injection causes tiredness and dizziness, which may impair your ability to drive, cycle, or operate machinery. Avoid doing so until the treatment.
• Pregnancy: Ceribulin 0.88mg Injection is unsafe for pregnant women as it may cause fetal harm. Inform your doctor promptly if you are pregnant, planning for pregnancy, or think you may get pregnant before starting the treatment with Ceribulin 0.88mg Injection.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.